Literature DB >> 6411202

Usefulness of apheresis to extract microfilarias in management of loiasis.

L Muylle, H Taelman, R Moldenhauer, R Van Brabant, M E Peetermans.   

Abstract

Two patients with loiasis in whom treatment with diethylcarbamazine had to be interrupted because of serious side effects underwent apheresis to extract microfilarias from the blood. After three apheresis sessions the number of microfilarias in the blood had dropped from 8980 to 3412/ml in one patient and from 2950 to 1840/ml in the other. Between 40 and 45 X 10(6) microfilarias were removed from each of the patients. After reduction of the parasitaemia the two patients were given diethylcarbamazine; no appreciable side effects occurred, and the patients were cured.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411202      PMCID: PMC1548441          DOI: 10.1136/bmj.287.6391.519

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  Encephalitis in loa-loa filariasis.

Authors:  L VAN BOGAERT; A DUBOIS; P G JANSSENS; J RADERMECKER; G TVERDY; M WANSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1955-05       Impact factor: 10.154

2.  [Current problems of loaiasis].

Authors:  A Fain
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

3.  [Loaiasis with high microfilaremia. Attempted extracorporal purification after exsanguination-transfusion].

Authors:  L C Brumpt; P Cornu; G Jaeger; J Y Neveu; R Parc
Journal:  Bull Soc Pathol Exot Filiales       Date:  1969 Sep-Oct

4.  Removal of microfilariae from unanaesthetized dogs by continuous flow centrifugation.

Authors:  W B Greenough; D Buckner
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

5.  Ascending paralysis associated with diethylcarbamazine treatment of M. loa loa infection.

Authors:  S L Stanley; O Kell
Journal:  Trop Doct       Date:  1982-01       Impact factor: 0.731

6.  [Treatment of filariases in a hospital setting. Complications - results].

Authors:  M Gentilini; B Carme
Journal:  Ann Soc Belg Med Trop       Date:  1981-06
  6 in total
  5 in total

1.  Apheresis in the management of loiasis with high microfilariaemia and renal disease.

Authors:  L Abel; V Ioly; P Jeni; C Carbon; A Bussel
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

2.  Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa.

Authors:  Jesica A Herrick; Michelle A Makiya; Nicole Holland-Thomas; Amy D Klion; Thomas B Nutman
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

3.  A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.

Authors:  Fanny Legrand; Jesica Herrick; Michelle Makiya; Roshan Ramanathan; Reagan Thompson; Shakuntala Rampertaap; Jennifer Stoddard; JeanAnne Ware; Michael P Fay; Nicole Holland-Thomas; Thomas B Nutman; Amy D Klion
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

4.  African eye worm.

Authors:  Etienne Rivière; Julien Kerautret; France Combillet; Denis Malvy
Journal:  J Glob Infect Dis       Date:  2012-04

5.  Loa loa in the Vitreous Cavity of the Eye: A Case Report and State of Art.

Authors:  Elisabetta Pallara; Sergio Cotugno; Giacomo Guido; Elda De Vita; Aurelia Ricciardi; Valentina Totaro; Michele Camporeale; Luisa Frallonardo; Roberta Novara; Gianfranco G Panico; Pasquale Puzo; Giovanni Alessio; Sara Sablone; Michele Mariani; Giuseppina De Iaco; Eugenio Milano; Davide F Bavaro; Rossana Lattanzio; Giulia Patti; Roberta Papagni; Carmen Pellegrino; Annalisa Saracino; Francesco Di Gennaro
Journal:  Am J Trop Med Hyg       Date:  2022-08-01       Impact factor: 3.707

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.